Why Has The Cellectar Biosciences (CLRB) Stock Price Gained 9.52% In After-Market Session?
Shares of Cellectar Biosciences Inc. (Nasdaq: CLRB) were up 9.52% at $2.30 at the time of the most recent check in after-hours trading following an equity move. What equity decision has CLRB made? The previously announced formal agreements between Cellectar Biosciences (CLRB) and a number of institutional investors (the “Investors”) to buy 3,275,153 shares of […]
